BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 30353665)

  • 1. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
    Srivastava A; Creek DJ
    Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics-based biomarkers: current status and potential use in the clinic.
    Quezada H; Guzmán-Ortiz AL; Díaz-Sánchez H; Valle-Rios R; Aguirre-Hernández J
    Bol Med Hosp Infant Mex; 2017; 74(3):219-226. PubMed ID: 29382490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development.
    Mikami T; Aoki M; Kimura T
    Curr Mol Pharmacol; 2012 Jun; 5(2):301-16. PubMed ID: 22122469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Omics" in oral cancer: New approaches for biomarker discovery.
    Rai V; Mukherjee R; Ghosh AK; Routray A; Chakraborty C
    Arch Oral Biol; 2018 Mar; 87():15-34. PubMed ID: 29247855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Predictive Biomarkers in Cancer.
    Nair M; Sandhu SS; Sharma AK
    Curr Cancer Drug Targets; 2014; 14(5):477-504. PubMed ID: 24807144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivaomics in oral cancer.
    Aro K; Kaczor-Urbanowicz K; Carreras-Presas CM
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):91-97. PubMed ID: 30507690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
    Ciocan-Cartita CA; Jurj A; Buse M; Gulei D; Braicu C; Raduly L; Cojocneanu R; Pruteanu LL; Iuga CA; Coza O; Berindan-Neagoe I
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
    Umelo IA; Costanza B; Castronovo V
    Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method.
    Gallardo-Gómez M; De Chiara L; Álvarez-Chaver P; Cubiella J
    Expert Rev Anticancer Ther; 2021 Jul; 21(7):723-738. PubMed ID: 33507120
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteomics for early detection of colorectal cancer: recent updates.
    Alnabulsi A; Murray GI
    Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Proteomics and the Elusive Diagnostic Biomarkers.
    Bradshaw RA; Hondermarck H; Rodriguez H
    Proteomics; 2019 Nov; 19(21-22):e1800445. PubMed ID: 31172665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational metabolomics in cancer research.
    Snyder NW; Mesaros C; Blair IA
    Biomark Med; 2015; 9(9):821-34. PubMed ID: 26329905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.
    Montaner J; Ramiro L; Simats A; Tiedt S; Makris K; Jickling GC; Debette S; Sanchez JC; Bustamante A
    Nat Rev Neurol; 2020 May; 16(5):247-264. PubMed ID: 32322099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry based proteomics and metabolomics in personalized oncology.
    Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of capillary electrophoresis for the early diagnosis of cancer.
    Yang Z; Sweedler JV
    Anal Bioanal Chem; 2014 Jul; 406(17):4013-31. PubMed ID: 24668067
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.